QuidelOrtho
QDEL
£19.05
Share price
-2.49%
Change (1 day)
-37.18%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.
QuidelOrtho (QDEL) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : £2.59 Billion
According to QuidelOrtho's latest financial reports the company's total liabilities are £2.59 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
QuidelOrtho - Total liabilities on balance sheet (from 2001 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | £2.74 B | -1.85% |
| 2023-12-31 | £2.79 B | -13.85% |
| 2022-12-31 | £3.24 B | 773.27% |
| 2021-12-31 | £0.37 B | -6.05% |
| 2020-12-31 | £0.39 B | 47.56% |
| 2019-12-31 | £0.26 B | -10.76% |
| 2018-12-31 | £0.29 B | -42.75% |
| 2017-12-31 | £0.52 B | 244.59% |
| 2016-12-31 | £0.15 B | 19.97% |
| 2015-12-31 | £0.12 B | -2.5% |
| 2014-12-31 | £0.13 B | 349.5% |
| 2013-12-31 | £28.92 M | 10.46% |
| 2012-12-31 | £26.18 M | -56.48% |
| 2011-12-31 | £60.16 M | -9.01% |
| 2010-12-31 | £66.12 M | 168.2% |
| 2009-12-31 | £24.65 M | 53.29% |
| 2008-12-31 | £16.08 M | 22.26% |
| 2007-12-31 | £13.15 M | 8.4% |
| 2006-12-31 | £12.13 M | -21.34% |
| 2005-12-31 | £15.42 M | 31.6% |
| 2004-12-31 | £11.72 M | -23.66% |
| 2003-12-31 | £15.35 M | 24.12% |
| 2002-12-31 | £12.37 M | -18.4% |
| 2001-12-31 | £15.16 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Meridian Bioscience VIVO | £71.16 M | -97.26% | 🇺🇸 USA |
 Becton Dickinson BDX | £21.88 B | 743.61% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | £37.10 B | 1,330.44% | 🇺🇸 USA |
 OraSure Technologies OSUR | £45.92 M | -98.23% | 🇺🇸 USA |
 Danaher DHR | £21.16 B | 715.70% | 🇺🇸 USA |
 PerkinElmer
PKI | £4.94 B | 90.63% | 🇺🇸 USA |